G.-L. Huang et al. / Carbohydrate Research 340 (2005) 603–608
607
3.7. Allyl 2-O-benzoyl-4,6-O-benzylidene-b-D-glucopyr-
anosyl-(1!3)-2-O-benzoyl-4,6-O-benzylidene-b-D-gluco-
pyranoside (10)
J3,4 = J4,5 9.7 Hz, H-4I), 5.89–5.82 (1H, m, –CH@),
5.62 (1H, dd, J2,3 = J3,4 9.7 Hz, H-3I), 5.53 (1H, s,
PhCH), 5.39 (1H, dd, J1,2 7.9, J2,3 9.8 Hz, H-2I), 5.35
(1H, s, PhCH), 5.32–5.21 (2H, m, @CH2), 5.00–4.81
(5H, m, H-1II, H-2I, H-2II, H-4I, H-4II), 4.53 (2H, m,
2H-6II), 4.46 (1H, d, J1,2 8.1 Hz, H-1I), 4.24 (1H, dd,
J5,6e 6.5, J6e,6a 12.3 Hz, H-6eIII), 4.13–4.02 (5H, m, H-
5I, H-5II, H-6aII, H-6eI, H-6aI), 3.91 (1H, dd,
J2,3 = J3,4 9.4 Hz, H-3II), 3.67 (1H, ddd, J4,5 9.7, J5,6e
5.8, J5,6a 5.7 Hz, H-5III); ESIMS: m/z 1143 [M+Na]+.
Anal. Calcd for C63H60O19: C, 67.50; H, 5.36. Found:
C, 67.24; H, 5.17.
To a soln of 9 (3.04 g, 3.7 mmol) in THF (125 mL) was
added HBF4 (0.36 g), and the mixture was stirred at rt
for 4 h, at the end of which time TLC (3:1 petroleum
ether–EtOAc) indicated that the reaction was complete.
The mixture was concentrated. The residue was passed
through a silica-gel column with 3:1 petroleum ether–
EtOAc as the eluent to give 10 as a foamy solid
(2.18 g, 80%): [a]D +20.3 (c 1.0, CHCl3); 1H NMR
(CDCl3, 400 MHz): d 7.51–7.34 (20H, m, Bz–H, Ph–
H), 5.91–5.82 (1H, m, –CH@), 5.57 (1H, s, PhCH),
5.34 (1H, s, PhCH), 5.33–5.21 (2H, m, @CH2), 5.21
(1H, dd, J3,4 = J2,3 9.6 Hz, H-3I), 5.05 (1H, d, J1,2
4.0 Hz, aH-1), 5.01 (1H, dd, J1,2 7.8, J2,3 9.6 Hz, H-
2I), 4.88 (1H, d, J1,2 7.8 Hz, H-1II), 4.86 (dd, J1,2 4.0,
J2,3 9.6 Hz, H-2), 4.32–4.16 (4H, m), 4.02–3.89 (2H,
m), 3.79–3.63 (4H, m), 3.49–3.42 (1H, m); ESIMS: m/z
789 [M+Na]+. Anal. Calcd for C43H42O13: C, 67.36;
H, 5.48. Found: C, 67.64; H, 5.35.
3.10. Allyl 3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-b-
D-glucopyranosyl-(1!3)-2-O-benzoyl-4,6-O-benzylidene-
b-D-glucopyranosyl-(1!3)-2-O-benzoyl-4,6-O-benzyl-
idene-b-D-glucopyranosyl-(1!3)-2-O-benzoyl-4,6-O-benz-
ylidene-b-D-glucopyranosyl-(1!3)-2-O-benzoyl-4,6-O-
benzylidene-b-D-glucopyranoside (13)
Compound 13 (79 mg, 82%) was obtained from 12
(2.05 g) following the procedure above described for
the preparation of 7 and 9: [a]D ꢀ1.8 (c 1.1, CHCl3);
1H NMR (CDCl3, 400 MHz): d 8.10–6.92 (50H, m,
Bz–H, PhH), 6.50 (1H, d, J 3.5 Hz, aH-1), 5.70 (1H,
m, –CH@), 5.65 (1H, dd, J2,3 = J3,4 7.0 Hz, H-3V),
5.26 (1H, dd, J1,2 5.3, J2,3 7.0 Hz, H-2V), 5.19–5.03
(2H, m, CH2@), 5.15–5.03 (4H, m), 5.00 (1H, m, H-
4IV), 4.95 (3H, m), 4.78 (1H, d, J1,2 4.8 Hz, H-1IV),
4.72–4.62 (5H, m), 4.52 (2H, m), 4.38–4.23 (3H, m),
4.15–4.06 (3H, m), 4.09–3.82 (2H, m, @CH–CH2–),
3.98–3.77 (5H, m), 3.63–3.57 (2H, m), 3.42 (1H, dd,
J3,4 5.3, J4,4 12.7 Hz, H-5I), 3.27 (1H, dd, J3,4 4.5, J4,4
12.6 Hz, H-5V), 3.21–3.10 (2H, m), 2.04 (3H, s,
CH3CO); ESIMS: m/z 1893 [M+Na]+. Anal. Calcd for
3.8. Allyl 3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-b-D-
glucopyranosyl-(1!3)-2-O-benzoyl-4,6-O-benzylidene-b-
D-glucopyranosyl-(1!3)-2-O-benzoyl-4,6-O-benzylidene-
b-D-glucopyranoside (11)
Compound 11 (88 mg, 49%) was obtained from 10
(2.18 mg) following the procedure above described for
the preparation of 7 and 9: [a]D ꢀ2.6 (c 1.0, CHCl3);
1H NMR (CDCl3, 400 MHz): d 7.51–7.34 (30H, m,
Bz–H, Ph–H), 6.42 (1H, d, 3.7 Hz, aH-1), 5.90 (1H,
dd, J3,4 = J4,5 9.7 Hz, H-4I), 5.89–5.82 (1H, m, –CH@),
5.64 (1H, dd, J2,3 = J3,4 9.7 Hz, H-3I), 5.57 (1H, s,
PhCH), 5.38 (1H, dd, J1,2 7.9, J2,3 9.8 Hz, H-2I), 5.34
(1H, s, PhCH), 5.33–5.21 (2H, m, @CH2), 5.02–4.81
(5H, m, H-1II, H-2I, H-2II, H-4I, H-4II), 4.56 (2H, m,
2H-6II), 4.46 (1H, d, J1,2 8.1 Hz, H-1II), 4.25 (1H, dd,
J5,6e 6.5, J6e,6a 12.3 Hz, H-6eIII), 4.16–4.04 (5H, m, H-
C
105H98O32: C, 67.38; H, 5.24. Found: C, 67.50; H, 5.30.
3.11. (R)-2,3-Epoxypropyl 3-O-acetyl-2-O-benzoyl-4,6-
O-benzylidene-b-D-glucopyranosyl-(1!3)-2-O-benzoyl-
4,6-O-benzylidene-b-D-glucopyranosyl-(1!3)-2-O-benz-
oyl-4,6-O-benzylidene-b-D-glucopyranosyl-(1!3)-2-O-
benzoyl-4,6-O-benzylidene-b-D-glucopyranosyl-(1!3)-2-
O-benzoyl-4,6-O-benzylidene-b-D-glucopyranoside (14)
5I, H-5II, H-6aIII
,
H-6eI, H-6aI), 3.91 (1H, dd,
J2,3 = J3,4 9.4 Hz, H-3I), 3.68 (1H, ddd, J4,5 9.7, J5,6e
5.8, J5,6a 5.7 Hz, H-5III), 2.19 (3H, s, CH3CO); ESIMS:
m/z 1185 [M+Na]+. Anal. Calcd for C65H62O20: C,
67.13; H, 5.34. Found: C, 67.00; H, 5.30.
To a soln of 13 (0.38 mmol) in CH2Cl2 (7 mL), m-
CPBA, (1.0 mmol) was added and the suspension was
stirred. When TLC showed that all starting compound
had been consumed (about 3 h), the reaction mixture
was washed successively with 5% aq NaOH and water,
dried (MgSO4), filtered and the filtrate evaporated to
dryness. The solids obtained were purified by recrystal-
lization from EtOH. The obtained materials were stored
3.9. Allyl 2-O-benzoyl-4,6-O-benzylidene-b-D-glucopyr-
anosyl-(1!3)-2-O-benzoyl-4,6-O-benzylidene-b-D-gluco-
pyranosyl-(1!3)-2-O-benzoyl-4,6-O-benzylidene-b-D-
glucopyranoside (12)
Compound 12 (2.05 g, 83%) was obtained from 11
(88 mg) following the procedure above described for
1
in the dark at 4 ꢁC: [a]D ꢀ1.1 (c 1.1, CHCl3); H NMR
1
the preparation of 10: [a]D +16.4 (c 1.0, CHCl3); H
(CDCl3, 400 MHz): d 8.10–6.92 (50H, m, Bz–H, Ph–H),
5.65 (1H, dd, J2,3 = J3,4 7.0 Hz, H-3V), 6.50 (1H, d,
3.5 Hz, aH-1), 5.26 (1H, dd, J1,2 5.3, J2,3 7.0 Hz,
NMR (CDCl3, 400 MHz): d 8.00–7.26 (30H, m, Bz–H,
Ph–H), 6.40 (1H, d, 3.7 Hz, aH-1), 5.90 (1H, dd,